A AEVUM / internal
Site Research Compliance Images
v0.5 · 2026-04-18 · For legal sign-off
Panel 03 / Compliance audit

MAB compliance audit of the marketing site.
Sentence-by-sentence, with rule reference.

Malaysia's Medicine Advertisement Board (MAB) — under the Medicines (Advertisement and Sale) Act 1956 and elaborated in the Pharmacy Act guidelines for healthcare facilities — strictly regulates what private healthcare clinics may say in their marketing material. The benchmarked B2C model used by Prenuvo, Ezra, Function Health and similar US-based providers is functionally illegal in Malaysia. This page documents how the AEVUM marketing site has been audited against the MAB rules, what was changed, and what remains for review by a Malaysian-registered healthcare lawyer prior to public launch.

Summary

Pages audited
1
index.html (primary site)
Violations identified
7
All flagged below
Violations fixed
7 / 7
Live on the site as of v0.5
Pending legal sign-off
1
Final consultant disclosure

01 · MAB rules at a glance

✗ Forbidden

Patient testimonials

"Mrs Tan from Bangsar said her scan saved her life" — not permitted, even if the testimonial is genuine and offered voluntarily.

MAB Guideline §3 · Pharmacy Act
✗ Forbidden

Celebrity endorsements

Kim Kardashian-style celebrity recommendation of a clinical service. No celebrity may endorse a treatment or service.

MAB Guideline §3
✗ Forbidden

Promoting individual practitioners' skills

"Our radiologists are the best in the region" / "world-renowned consultant" / "Dr X is internationally acclaimed". Listing names & basic qualifications for verification is allowed; framing as superior expertise is not.

MAB Guideline §4
✗ Forbidden

Comparing prices or packages between clinics

"Our scan is 50% cheaper than Hospital X" / "We charge less than Mt Elizabeth". Even factually true comparisons are prohibited.

MAB Guideline §5
✗ Forbidden

Free offers of healthcare services

"First consultation free" / "Complimentary follow-up visit". Bundled inclusions inside a paid package are different and are permitted.

MAB Guideline §6
✗ Forbidden

Exaggerated, false, misleading, or deceptive claims

Catch-all clause. Includes "the most comprehensive scan in the region", "guaranteed early detection", "the only clinic that…".

Medicines Act 1956 §4
✓ Permitted

Bundled package pricing

"Our Comprehensive package: full-body MRI + 60-min consultation + bound report = RM 8,699." This is permitted. Itemised inclusions inside the bundle are permitted.

MAB Guideline §7
✓ Permitted

Time-limited package discounts

"15% off the Comprehensive package during Mother's Day week" / "Founders' Programme rate, valid Q3 2026 only" — explicit time-limited discounts on full bundled packages are permitted.

MAB Guideline §7
✓ Permitted

Factual disclosure of practitioners on register

Listing the names, MMC registration numbers, and basic qualifications (MBBS, MMed, FRCR) of practitioners — required under Act 586 anyway. The line is between disclosure (permitted) and promotion (not).

Act 586 §38 + MAB Guideline §4
✓ Permitted

Facility & technology description

"5,000 sq ft facility, three Siemens MAGNETOM magnets, RF-shielded suites, on-site emergency capability." Factual descriptions of facility, equipment, and technology are permitted in full.

MAB Guideline §8

02 · Audit findings — index.html

Each violation identified, with the original phrasing, the MAB rule cited, the rewrite applied, and the reason. All seven violations have been fixed in the live site as of v0.5.

Ref. Status Before / Rule After / Reason
A-01 FIXED FAQ — "How is AEVUM different from Prenuvo, Ezra, or Function Health?"
/ Section 09, FAQ accordion item 3
"We are slower and more expensive than Ezra, but we are still 35–40% cheaper than the equivalent Singapore hospital concierge package." Direct comparison of prices for healthcare services between AEVUM and other clinics. "We do not publish comparisons against the prices of other clinics; the right scan for you depends on your individual clinical context, and we will discuss that openly during your initial intake." MAB Guideline §5. All inter-clinic price comparisons removed. The bundled package price (RM 8,699 etc.) is retained — bundled pricing is explicitly permitted.
A-02 FIXED Section 02 heading
/ Specialists section
"Named, credentialed, available to sit with you for an hour." Frames consultants as personally distinguished — a soft promotion of individual practitioner skill. "Our consultant radiologists. Listed publicly, registered with the MMC." MAB Guideline §4. Reframed as factual disclosure (per Act 586) rather than promotion. The MMC reference signals regulatory compliance.
A-03 FIXED Specialist credentials
/ All three consultant cards
"FRCR (UK) · 18 years post-fellowship"
"Former senior consultant, SGH Diagnostic Imaging"
"Subspecialty: oncologic body imaging" Years of experience and prior senior positions are framed as superior expertise. "Subspecialty" implies differentiated skill. "FRCR (UK)" (years removed)
(Former positions removed entirely)
"Areas of clinical practice: oncologic MRI, body imaging" MAB Guideline §4. Reduced to MMC-style factual disclosure. Names and degree qualifications retained (required under Act 586). Each card now ends with "MMC Reg. No. pending registration" — appropriate disclosure language.
A-04 FIXED Honesty card 03 — "What the literature says"
/ Section 06, Evidence triangle
"We disagree, partially. We agree the marketing of WB-MRI by US disruptors has been irresponsible." Implicit comparison to other providers ("US disruptors"); self-positioning as morally superior is comparative framing. "Our practice engages with this debate directly. We accept that not every patient is a suitable candidate for asymptomatic full-body MRI screening, and we will say so during the intake conversation if we believe so in your case." MAB Guideline §6. Reframed as honest patient-counselling commitment rather than comparison. Strengthens trust without comparing to competitors.
A-05 FIXED Legacy Platinum tier description
/ Section 04, Packages
"The most comprehensive preventative scan in the region." Superlative claim ("the most comprehensive in the region") is a comparative quality claim that could be characterised as exaggerated. "Our broadest tier — full-body MRI plus a low-dose CT and laboratory biomarker panel." MAB Guideline §6. Replaced superlative with factual itemised description. "Our broadest tier" is internal comparative (within AEVUM's own tier ladder), which is permitted.
A-06 FIXED Longitudinal section
/ Section 07, 12-month re-read
"…included in the Comprehensive tier and above, complimentary in the first year for all tiers." "Complimentary" reads as a free service offer — formally not permitted for healthcare services. "…included as part of the bundled package price for the Comprehensive tier and above, and included for the first year as part of the Core tier package price." MAB Guideline §6. Reframed as bundled-package inclusion rather than free offer. The 12-month re-read is paid for as part of the package price — semantically and legally distinct from "complimentary".
A-07 FIXED Section 02 sub-meta
/ Specialists section header
"Subject-matter expertise" Reads as marketing claim of superior knowledge. "Practitioners on register · Act 586 disclosure" MAB Guideline §4. Reframed as regulatory-disclosure context, the same way a hospital's "Our Doctors" page reads.
A-08 PENDING Practitioner names overall
/ Section 02, all three cards
The site currently shows three named consultants: Dr. Aminah Lim, Dr. Rajesh Balachandran, Dr. Marcus Tan Wei Liang. These are illustrative placeholders for the draft site. Final consultant appointments are pending. A disclaimer has been added to the spec-note: "Practitioner names shown are illustrative for the purposes of this draft site. Final consultant appointments will be confirmed and listed with their MMC registration numbers prior to clinic opening, as required under the Private Healthcare Facilities and Services Act 1998 (Act 586)." Pending action: Replace placeholder names with actual hires once recruited (target Q3 2026, ahead of clinic opening). At that point each card must show real MMC registration number.

03 · Scope of audit · what is not in scope

In scope

index.html (primary marketing site)

The public-facing AEVUM site that potential guests will visit. All consumer-facing copy here is subject to MAB review and has been audited above.

Out of scope (internal)

admin.html · admin-insights.html · this page

These are internal strategy and research panels. They contain inter-clinic price comparisons, pricing strategy analyses, and competitor positioning material. This content is appropriate inside an internal strategy document but must NOT be reused in any consumer-facing marketing. Pre-launch, these pages should be password-gated or removed from the public site.

Out of scope (archived)

style-*.html files (selector + archived drafts)

Style exploration drafts kept for design-direction comparison. Pre-launch, these should be removed from the public site or moved to a password-protected staging URL. Re-audit any draft that becomes the live site.

Out of scope (future)

Bahasa Indonesia microsite, future pre-booking pages, blog posts

Any future content added to the public AEVUM site must be re-audited under the same MAB framework before publication. The Bahasa Indonesia microsite is particularly sensitive — translation can introduce subtle promotional emphasis that the original English avoided.

04 · Pre-launch sign-off block

For the appointed Malaysian-registered healthcare lawyer

The internal audit above is a starting point, not a substitute for legal opinion. Before the AEVUM site is published in production form (i.e. with real consultant names, in a way that constitutes "advertising" to the Malaysian public), this audit should be reviewed and signed off by Malaysian-registered legal counsel competent in healthcare advertising regulation.

Recommended additional checks the lawyer should perform: (1) confirm A-08 once consultant hires are finalised; (2) review every imported asset (photography, video) for incidental MAB exposure; (3) approve the launch press release and any paid-channel ad copy; (4) confirm the Bahasa Indonesia translation does not materially change the regulatory weight of any sentence.

Date of review
Lawyer name
Firm
Bar / MAA reference
Outstanding items
Signature